Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas - dual roles for CD40 and Fas (CD95) ligands modulated by the B cell antigen receptor

By Chaperot L.   Delfau-Larue M.-H.   Jacob M.-C.   Molens J.-P.   Roussel B.   Agrawal S.   Farcet J.-P.   Gressin R.   Sotto J.-J.   Bensa J.-C.   Plumas J.  

Experimental Hematology, Vol. 27, Iss. 7, 1999-07 ,pp. : 1185-1193

Elsevier

Access to resources Recommend Favorite

Expression of Inhibitory Receptors in Natural Killer (CD3^-CD56⁺) Cells and CD3⁺CD56⁺ Cells in the Peripheral Blood Lymphocytes and Tumor Infiltrating Lymphocytes in Patients with Primary Hepatocellular Carcinoma

By Yuen M-F.   Norris S.  

Clinical Immunology, Vol. 101, Iss. 3, 2001-12 ,pp. : 264-269

Academic Press

Access to resources Recommend Favorite

Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4 + T cell priming and CD8 + T cell effector functions

By Mortara Lorenzo   Frangione Valeria   Castellani Patrizia   De Lerma Barbaro Andrea   Accolla Roberto S.  

International Immunology, Vol. 21, Iss. 6, 2009-06 ,pp. : 655-665

Oxford University Press

Access to resources Recommend Favorite

MUC1‐specific anti‐tumor responses: molecular requirements for CD4‐mediated responses

By VanLith Michelle L.   Kohlgraf Karl G.   Sivinski Connie L.   Tempero Richard M.   Hollingsworth Michael A.  

International Immunology, Vol. 14, Iss. 8, 2002-08 ,pp. : 873-882

Oxford University Press

Access to resources Recommend Favorite

Characterization of CD4 + CD8αα + and CD4 - CD8αα + intestinal intraepithelial lymphocytes in rats

By Yamada K.  

International Immunology, Vol. 11, Iss. 1, 1999-01 ,pp. : 21-28

Oxford University Press

Access to resources Recommend Favorite